{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:51:00Z","timestamp":1791154260926,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Association for Training, Education and Research in Hematology, Immunology and Transplantation."},{"name":"Hospital Clinical Research Program"},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bbmt.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T21:06:43Z","timestamp":1411160803000},"page":"620-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["High-Dose Total Body Irradiation and Myeloablative Conditioning before Allogeneic Hematopoietic Cell Transplantation: Time to Rethink?"],"prefix":"10.1016","volume":"21","author":[{"given":"Mohamad","family":"Mohty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.09.010_bib1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.09.010_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1158\/1055-9965.EPI-06-0714","article-title":"Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study","volume":"16","author":"Shankar","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bbmt.2014.09.010_bib3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbmt.2014.04.021","article-title":"Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experience","volume":"20","author":"Malard","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib4","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib5","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib6","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1038\/bcj.2011.14","article-title":"Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update","volume":"1","author":"Mohty","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bbmt.2014.09.010_bib7","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2002-07-2231","article-title":"Nonmalignant late effects after allogeneic stem cell transplantation","volume":"101","author":"Socie","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/ehm.09.48","article-title":"Late complications after hematopoietic stem cell transplantation","volume":"2","author":"Tichelli","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bbmt.2014.09.010_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/asheducation-2010.1.229","article-title":"Long-term physiological side effects after allogeneic bone marrow transplantation","volume":"2010","author":"Mohty","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2014.09.010_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.7326\/0003-4819-119-12-199312150-00004","article-title":"Cataract formation after bone marrow transplantation","volume":"119","author":"Tichelli","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2014.09.010_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0360-3016(98)00077-7","article-title":"Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation","volume":"41","author":"Belkacemi","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 2s","key":"10.1016\/j.bbmt.2014.09.010_bib12","article-title":"Spermatogenesis recovery in male survivors after HSCT: evidence for graft-versus-testis effect, on behalf of the Late Effects Working Party\u2013EBMT","volume":"45","author":"Rovo","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bbmt.2007.06.008","article-title":"Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Kersting","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/cncr.23773","article-title":"Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation","volume":"113","author":"Choi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2014.09.010_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbmt.2008.03.008","article-title":"Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation","volume":"14","author":"Al-Hazzouri","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1703312","article-title":"Renal function after autologous bone marrow transplantation in children: a long-term prospective study","volume":"29","author":"Frisk","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplant","volume":"39","author":"Hingorani","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2008.07165.x","article-title":"Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation","volume":"142","author":"Tichelli","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.09.010_bib20","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-131-10-199911160-00004","article-title":"Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group","volume":"131","author":"Kolb","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2014.09.010_bib22","first-page":"453","article-title":"Malignant neoplasms in long-term survivors of bone marrow transplantation\u2014follow up","volume":"112","author":"Heilmeier","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2014.09.010_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2007-07-099283","article-title":"Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party","volume":"111","author":"Friedman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning","author":"Ringden","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib27","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib28","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2007-06-096966","article-title":"Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences","volume":"110","author":"Sorror","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib29","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1200\/JCO.2013.48.8114","volume":"31","author":"Nagler","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.09.010_bib30","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1182\/blood-2013-07-514448","article-title":"Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI","volume":"122","author":"Copelan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.09.010_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5500\/wjt.v3.i4.99","article-title":"Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies","volume":"3","author":"Cheuk","year":"2013","journal-title":"World J Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.09.010_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.04.005","article-title":"Personalized busulfan and\u00a0treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics","author":"Ten Brink","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bbmt.2014.09.010_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"5","author":"Majhail","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114005655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114005655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:07Z","timestamp":1761058267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114005655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1083879114005655"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.09.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose Total Body Irradiation and Myeloablative Conditioning before Allogeneic Hematopoietic Cell Transplantation: Time to Rethink?","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}